Cite

HARVARD Citation

    Zhou, L. et al. (2021). Allogeneic hematopoietic stem cell transplantation could improve the survival of acute myeloid leukemia patients with ASXL1 mutations. Hematology. 26 (1), pp. 340-347. [Online]. 
  
Back to record